PSEN2 and Alzheimer disease: Considering that PER is generally cognitively neutral in people with epilepsy (86), including in older adults with epilepsy (38), we sought to quantify the anticonvulsant potency and tolerability of PER against acute 6-Hz focal seizures in PSEN2-KO mice to further define therapeutic potential of this agent for older adults with seizures and AD.